In this current study, we assess the role of gp78 in breast cancer by characterizing its protein expression in a large (>500 patients) cohort of patients with breast cancer and defining its association with patient and tumor characteristics and features, including survival, grade, subtype, race/ethnicity (self-identified), and gene expression. The gene discussed is AMFR; the disease is neoplasm.